Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

C3_CORPUS_UTERI_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C54
  • Hospital discharge: ICD-9 182
  • Hospital discharge: ICD-8 1820
  • Cause of death: ICD-10 C54
  • Cause of death: ICD-9 182
  • Cause of death: ICD-8 1820
  • Cancer registry: Topography ICD-O-3 C54
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

3600

4. Check minimum number of events

None

3600

5. Include endpoints

None

3600

6. Filter based on genotype QC (FinnGen only)

3600

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

List of similar endpoints to Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 3600 3600 -
Unadjusted period prevalence (%) 1.23 1.23 -
Median age at first event (years) 65.17 65.17 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2768
Matched controls
27677
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
323.0
313
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
323.0
401
*
B01AB10
ATC
tinzaparin; parenteral
17.1
323.0
773
613
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
323.0
705
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
23.6
323.0
588
312
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
+∞
323.0
414
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
2358.9
323.0
541
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
8.3
323.0
838
1372
ZXC96
NOMESCO Finland
Robot assisted procedure
122.1
323.0
509
51
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
323.0
1583
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
37.6
323.0
1527
877
H02AB02
ATC
dexamethasone; systemic
57.3
323.0
574
126
N95.0
ICD-10 Finland
Postmenopausal bleeding
11.2
323.0
1353
2171
128
Kela drug reimbursment
Cancers of female genital organs
10333.8
323.0
767
*
JN4BD
NOMESCO Finland
Extensive body CT
15.0
323.0
699
610
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
323.0
2240
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
105.1
323.0
941
135
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
323.0
645
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
5.0
323.0
1520
5413
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
6.9
316.8
923
1871
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
11.5
300.5
601
651
B01AB05
ATC
enoxaparin; parenteral
4.6
297.5
1549
6007
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
2871.0
285.2
271
*
LCA06
NOMESCO Finland
Biopsy of endometrium
5.7
278.4
963
2370
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.1
278.0
400
185
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
736.0
275.1
267
*
XX3DW
NOMESCO Finland
Time consuming IT work
10.7
261.5
540
611
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
10.6
247.7
514
583
JN4AD
NOMESCO Finland
Body CT examination
13.4
247.4
453
398
L02BG04
ATC
letrozole; oral
137.1
246.2
261
21
A03FA01
ATC
metoclopramide; systemic, rectal
5.2
243.7
899
2325
L03AA13
ATC
pegfilgrastim; parenteral
2371.5
240.0
229
*
LCD00
NOMESCO Finland
Hysterectomy
8.1
236.2
579
870
115
Kela drug reimbursment
Breast cancer
+∞
230.5
218
*
A04AA01
ATC
ondansetron; systemic, rectal
14.6
228.5
401
317
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
798.1
227.5
221
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
221.9
210
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
209.0
198
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
209.0
198
*
PJA12
NOMESCO Finland
Sentinel node biopsy
370.9
208.9
208
6
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
90.7
202.8
225
27
C54.19
ICD-10 Finland
Malignant tumor of endometrium, unspecified histology
+∞
199.4
189
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
515.6
196.0
193
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
195.1
1149
4458
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
+∞
194.1
184
*
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
5.3
192.2
669
1565
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
246.1
180.8
184
8
A04AA02
ATC
granisetron; systemic, transdermal
173.8
171.8
179
11
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1756.1
166.3
160
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
162.1
154
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
103.7
160.2
175
18
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
19.0
155.7
244
140
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
152.5
145
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
1542.8
149.3
144
*
1820A
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]
+∞
149.3
142
*
8441/3-C54.1
ICD-O-3
Serous carcinoma, NOS, of endometrium
+∞
142.9
136
*
130
Kela drug reimbursment
Malignant tumour
+∞
142.9
136
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
34.9
142.1
186
57
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
135.5
129
*
LE090
NOMESCO Finland
Profylactive radiotherapy of vulva and vagina
+∞
133.4
127
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
67.4
132.5
153
24
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
132.3
126
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
130.9
788
2923
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
130.2
124
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
129.2
123
*
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
40.2
128.7
163
43
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
126.0
120
*
ULC02
NOMESCO Finland
Hysteroscopy
5.1
123.0
423
937
L02BA01
ATC
tamoxifen; oral
255.0
119.9
122
5
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
116.5
111
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
116.5
111
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
207.1
115.5
119
6
N84.0
ICD-10 Finland
Polyp of corpus uteri
3.9
114.5
545
1652
WF090
NOMESCO Finland
Profylactic radiotherapy
1111.1
110.2
107
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
110.1
105
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
110.1
105
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
135.6
109.9
117
9
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
109.1
104
*
WF002
NOMESCO Finland
Radical radiotherapy
63.3
109.0
127
21
TPH07
NOMESCO Finland
Cathetrisation of artery
4.3
108.8
449
1191
WX402
NOMESCO Finland
General anaesthesia
3.7
107.0
544
1734
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
1067.9
106.0
103
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
537.8
105.4
104
*
C54.13
ICD-10 Finland
Clear cell carcinoma of the endometrium
+∞
103.8
99
*
JAL30
NOMESCO Finland
Omentectomy
34.5
103.1
135
41
Z51.5
ICD-10 Finland
Palliative care
9.2
102.2
223
261
HAC20
NOMESCO Finland
Total mastectomy
346.0
100.8
101
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.6
100.4
213
237
HA1AA
NOMESCO Finland
X-ray mammography
6.0
99.7
295
541
LEB00
NOMESCO Finland
Biopsy of vagina
9.8
96.3
202
220
ZX070
NOMESCO Finland
Intensity modified radiotherapy
928.3
92.4
90
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
885.7
88.2
86
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
88.0
84
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
88.0
84
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.8
87.6
211
289
WF099
NOMESCO Finland
Other radiotherapy
158.5
87.6
92
6
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.5
83.8
134
80
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
832.5
82.9
81
*
L03AA02
ATC
filgrastim; parenteral
103.3
82.4
90
9
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
81.5
498
1792
LCD30
NOMESCO Finland
Radical hysterectomy
168.9
78.5
82
5
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.7
78.4
210
335
JN4CD
NOMESCO Finland
Very extensive body CT
10.4
76.2
154
156
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
758.3
75.6
74
*
C54
ICD-10 Finland
Malignant neoplasm of corpus uteri
758.3
75.6
74
*
X77
ICPC
Malignant neopl genital female other
747.8
74.6
73
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
74.3
71
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
377.1
74.1
74
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
4.0
69.4
306
844
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
69.0
66
*
C54.23
ICD-10 Finland
Carcinosarcoma
+∞
69.0
66
*
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
143.5
66.2
70
5
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
65.9
63
*
WZC30
NOMESCO Finland
Teaching
3.2
65.0
376
1286
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
9.5
64.0
135
148
ZX080
NOMESCO Finland
Image guided radiotherapy
632.1
63.1
62
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
88.5
62.2
69
8
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
62.1
1105
6826
L01BC06
ATC
capecitabine; oral
+∞
60.6
58
*
C54.22
ICD-10 Finland
Endometrial stromal cell sarcoma
+∞
60.6
58
*
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
17.7
60.6
96
56
C54.0
ICD-10 Finland
Malignant neoplasm: Isthmus uteri
+∞
59.6
57
*
WF004
NOMESCO Finland
Palliative radiotherapy
590.2
58.9
58
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.9
58.5
410
1590
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
8.1
57.8
134
172
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
57.3
727
3866
Z51.0
ICD-10 Finland
Radiotherapy session
569.3
56.8
56
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
569.3
56.8
56
*
C55
ICD-10 Finland
Malignant neoplasm of uterus, part unspecified
+∞
56.4
54
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.2
56.2
229
585
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
558.9
55.8
55
*
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
55.4
53
*
WW500
NOMESCO Finland
Blood transfusion
6.5
52.8
142
227
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
52.2
50
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
75.4
52.2
59
8
8310/3-C54.1
ICD-O-3
Clear cell adenocarcinoma, NOS, of endometrium
+∞
51.2
49
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
48.7
2514
22173
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
486.0
48.5
48
*
18200
ICD-8 Finland
Other malignant neoplasm of uterus, Carcinoma corporis uteri
+∞
48.0
46
*
ZX120
NOMESCO Finland
Intravenous
3.1
47.5
281
967
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
47.0
298
1075
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
46.0
44
*
L02BG03
ATC
anastrozole; oral
+∞
46.0
44
*
C50
ICD-10 Finland
Malignant neoplasm of breast
159.3
44.9
47
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
44.9
43
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
44.9
43
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
44.9
43
*
Z31.5
ICD-10 Finland
Genetic counselling
5.6
44.8
135
250
LCA10
NOMESCO Finland
Curettage of body of uterus
4.5
44.6
165
383
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
119.5
43.9
47
*
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
4.1
43.4
180
466
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
43.0
340
1403
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
42.8
41
*
LC003
NOMESCO Finland
Adjuvant radiotherapy of uterus and uterine ligaments
+∞
42.8
41
*
A04AD12
ATC
aprepitant; systemic
218.2
42.0
43
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
41.8
40
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
41.8
40
*
8140/3-C54.1
ICD-O-3
Adenocarcinoma, NOS, of endometrium
+∞
41.8
40
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
31.1
41.5
55
18
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
413.5
41.2
41
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
413.5
41.2
41
*
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
+∞
40.7
39
*
N02AA05
ATC
oxycodone; systemic
2.3
40.6
435
2097
A79
ICPC
Malignancy NOS
54.2
40.5
48
9
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
10.7
39.8
78
75
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
39.7
38
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
19.1
39.3
60
32
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
38.6
37
*
8980/3-C54.1
ICD-O-3
Carcinosarcoma, NOS, of endometrium
+∞
38.6
37
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.6
38.2
101
158
B02AA02
ATC
tranexamic acid; systemic
2.1
37.6
484
2529
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
37.3
1217
8757
X76
ICPC
Malignant neoplasm breast female
372.1
37.1
37
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
372.1
37.1
37
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
45.7
36.9
45
10
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
36.5
35
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
54.5
36.4
43
8
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
36.4
250
944
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
4.6
36.1
129
289
A04AA03
ATC
tropisetron; systemic
361.8
36.0
36
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
35.5
34
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
35.5
34
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
35.5
34
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
351.5
35.0
35
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
34.4
33
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
34.4
33
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
11.7
34.3
64
56
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
34.3
325
1469
JAL00
NOMESCO Finland
Biopsy of peritoneum
25.1
33.6
47
19
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
33.4
32
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
7.0
33.1
83
121
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
32.3
31
*
ZZR00
NOMESCO Finland
Flap of skin
15.6
31.7
52
34
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.9
31.6
64
66
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.4
31.6
161
495
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
31.3
30
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
31.3
30
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
31.0
142
401
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
30.3
29
*
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
30.3
29
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
30.3
29
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.9
30.1
100
208
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
305.6
29.8
30
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
10.2
29.6
59
59
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
4.8
29.6
101
216
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
29.2
28
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
29.2
28
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
294.9
28.8
29
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.6
28.6
75
117
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
28.2
27
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
28.2
27
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
15.6
28.1
46
30
ZXC40
NOMESCO Finland
Use of ultrasound
12.8
27.6
49
39
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
41.7
26.8
33
8
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
26.1
25
*
C54.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of corpus uteri
+∞
26.1
25
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
26.1
25
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
26.0
215
900
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.9
25.8
160
565
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
40.5
25.8
32
8
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.0
25.7
84
172
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.8
25.3
109
293
8306
FHL
Hysterectomy (related to abortion 8516, prolapse correction 8436)
0.1
25.2
12
960
B01AB04
ATC
dalteparin; parenteral
2.7
25.0
180
697
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
25.0
24
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
25.0
24
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
25.0
24
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
25.0
24
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
25.0
24
*
JAH01
NOMESCO Finland
Laparoscopy
3.2
24.8
134
431
8310
FHL
Radical hysterectomy (includes lymph node removal)
252.3
24.7
25
*
ULA02
NOMESCO Finland
Kolposcopy
2.2
24.6
280
1372
HAB99
NOMESCO Finland
Other partial excision of mammary gland
7.0
24.5
61
89
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
48.8
24.3
29
6
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
24.0
23
*
KA1FN
NOMESCO Finland
Isotope renography
19.2
23.9
36
19
JEA00
NOMESCO Finland
Appendectomy
2.8
23.4
158
589
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.0
23.2
138
473
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
22.9
22
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
22.9
22
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.2
22.8
121
384
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
22.5
172
691
L02BG06
ATC
exemestane; oral
+∞
21.9
21
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
21.9
21
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
221.6
21.6
22
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
115.9
21.6
23
*
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.7
21.1
454
2801
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
0.4
20.9
65
1777
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
20.9
20
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
20.9
20
*
8931/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, low grade of endometrium
+∞
20.9
20
*
JAH00
NOMESCO Finland
Laparotomy
4.1
20.8
82
204
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
8.0
20.5
46
58
21899
ICD-8 Finland
Uterine fibroma
0.3
20.4
56
1617
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
48.4
20.2
24
5
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
19.8
19
*
R50.9
ICD-10 Finland
Fever, unspecified
1.9
19.8
297
1623
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
105.8
19.6
21
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
105.8
19.6
21
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.5
19.6
94
278
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
18.8
18
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
18.8
18
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
18.8
18
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
18.8
18
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
18.8
18
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.3
18.7
21
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
70.3
18.7
21
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
18.7
258
1366
X12
ICPC
Postmenopausal bleeding
5.9
18.6
52
90
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
191.2
18.5
19
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
18.2
305
1731
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
25.2
18.2
25
10
WX725
NOMESCO Finland
Noninvasive ventilation
2.7
17.8
126
485
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
17.8
174
796
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
17.7
17
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
17.7
17
*
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.3
17.6
47
1379
XX1AD
NOMESCO Finland
Other CT-examination
95.6
17.6
19
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
181.1
17.5
18
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
181.1
17.5
18
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.8
17.3
57
120
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.0
17.1
42
61
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
17.1
318
1869
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
50.3
17.0
20
*
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
10.1
16.9
33
33
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
22.0
16.8
24
11
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
12.1
16.8
30
25
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
16.7
16
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
16.7
16
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
170.9
16.5
17
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.9
16.2
98
342
ZX112
NOMESCO Finland
Subcutaneous
7.3
16.0
38
53
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
24.6
16.0
22
9
Z3232
NOMESCO Finland
Midwife
3.1
16.0
91
305
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
15.9
118
467
R2110
NOMESCO Finland
Giving the first information
2.0
15.9
198
1007
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
15.8
82
259
S18
ICPC
Laceration/cut
1.4
15.8
1056
8417
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
15.6
15
*
8980/3-C54.9
ICD-O-3
Carcinosarcoma, NOS, of corpus uteri
+∞
15.6
15
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
15.6
15
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
15.6
15
*
XX1XN
NOMESCO Finland
Other isotope examination
85.6
15.6
17
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
22.2
15.5
22
10
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
0.2
15.5
17
787
WX704
NOMESCO Finland
Intubation
2.2
15.3
166
796
JFB00
NOMESCO Finland
Partial resection of small intestine
4.4
15.1
54
124
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
5.9
14.9
41
70
Z70.8
ICD-10 Finland
Other sex counselling
31.9
14.8
19
6
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
57.0
14.8
17
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.3
14.8
27
24
1XA02
NOMESCO Finland
NA
+∞
14.6
14
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
14.6
14
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
150.7
14.5
15
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
150.7
14.5
15
*
SPAT1153
SPAT
Removal of sutures
1.4
14.0
819
6334
G03AC03
ATC
levonorgestrel; systemic
0.5
13.9
103
2043
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.6
13.7
39
70
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.5
13.7
26
25
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
13.6
13.7
23
17
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
9.1
13.7
28
31
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
12.1
13.6
24
20
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
13.5
13
*
X75
ICPC
Malignant neoplasm cervix
+∞
13.5
13
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
13.5
13
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
13.5
13
*
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.4
13.5
77
1665
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
140.6
13.5
14
*
N81.1
ICD-10 Finland
Cystocele
0.5
13.4
116
2191
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
13.4
476
3320
LCD97
NOMESCO Finland
Other laparoscopic hysterectomy
21.2
13.3
19
9
N93
ICD-10 Finland
Other abnormal uterine and vaginal bleeding
21.2
13.3
19
9
E66.9
ICD-10 Finland
Obesity, unspecified
2.6
13.1
95
373
A46
ICD-10 Finland
Erysipelas
1.6
13.0
344
2231
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.7
13.0
56
154
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
50.2
12.8
15
*
A06AH03
ATC
naloxegol; oral
8.1
12.8
28
35
KA3EB
NOMESCO Finland
Antegrade pyelography
15.5
12.6
20
13
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
15.5
12.6
20
13
LCA98
NOMESCO Finland
Other transluminal endoscopic operation on uterus
5.3
12.5
37
70
3AA13
NOMESCO Finland
NA
+∞
12.5
12
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
12.5
12
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
12.5
12
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
12.5
12
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
12.5
12
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
12.5
12
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
12.5
12
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
12.5
12
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
12.5
12
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
12.5
12
*
C54.20
ICD-10 Finland
Malignant tumor of the myometrium without histology
+∞
12.5
12
*
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
17.4
12.5
19
11
R18
ICD-10 Finland
Ascites
4.5
12.2
42
94
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
37.7
12.2
15
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
12.2
620
4650
N85.9
ICD-10 Finland
Noninflammatory disorder of uterus, unspecified
3.9
12.1
49
128
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.9
12.0
48
124
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
11.7
11.8
21
18
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
16.5
11.7
18
11
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
30.1
11.6
15
5
LWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gynaecological surgery
30.1
11.6
15
5
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
65.2
11.6
13
*
N30.4
ICD-10 Finland
Irradiation cystitis
65.2
11.6
13
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
11.5
11
*
8461/3-C54.1
ICD-O-3
High grade serous carcinoma of endometrium
+∞
11.5
11
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
11.5
11
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
11.5
11
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
11.5
11
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
11.5
11
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
11.5
11
*
8140/3-C54.9
ICD-O-3
Adenocarcinoma, NOS, of corpus uteri
+∞
11.5
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.5
11
*
L02BA03
ATC
fulvestrant; parenteral
+∞
11.5
11
*
8930/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, NOS, of endometrium
+∞
11.5
11
*
D75
ICPC
Malignant neoplasm colon/rectum
120.5
11.4
12
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
7.5
11.4
26
35
WX110
NOMESCO Finland
Local anesthesy
1.3
11.4
1562
13706
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
2.1
11.3
129
633
LCD11
NOMESCO Finland
Laparoscopically assisted vaginal hysterectomy
2.9
11.3
66
228
R07.4
ICD-10 Finland
Chest pain, unspecified
0.7
11.2
468
6209
8305
FHL
Supravaginal amputation or resection
0.2
11.0
7
457
WX400
NOMESCO Finland
Inhalation anesthesy
2.3
11.0
99
437
NK6AN
NOMESCO Finland
Total body bone isotope imaging
10.1
11.0
21
21
A40.8
ICD-10 Finland
Other streptococcal sepsis
6.6
10.9
27
41
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
7.4
10.9
25
34
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
43.5
10.9
13
*
J01DB01
ATC
cefalexin; oral
1.3
10.9
2033
18603
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
2.3
10.9
99
441
ZX121
NOMESCO Finland
Central venous catheter
17.9
10.7
16
9
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.7
10.7
218
1315
X81
ICPC
Genital neopl female other/unspecif
21.5
10.7
15
7
5703
FHL
Removal of lymph nodes from the retroperitoneal space
21.5
10.7
15
7
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.3
10.7
38
89
XW2AT
NOMESCO Finland
Cytology of deep organ with ultrasound quidance
60.2
10.6
12
*
E66.8
ICD-10 Finland
Other obesity
2.1
10.6
115
555
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
10.6
181
1034
JFB30
NOMESCO Finland
Right hemicolectomy
6.5
10.5
26
40
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
110.4
10.4
11
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
110.4
10.4
11
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
10.4
10
*
18220
ICD-8 Finland
NA
+∞
10.4
10
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
10.4
10
*
159
Kela drug reimbursment
Pazopanib
+∞
10.4
10
*
8323/3-C54.1
ICD-O-3
Mixed cell adenocarcinoma of endometrium
+∞
10.4
10
*
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
+∞
10.4
10
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
10.4
10
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
10.4
10
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
10.4
10
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
10.4
10
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
32.6
10.3
13
*
JFF23
NOMESCO Finland
Transversostomy
8.2
10.3
22
27
KAC10
NOMESCO Finland
Total nephrectomy with capsule
23.4
10.2
14
6
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
3.4
10.2
47
138
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
7.9
10.1
22
28
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
10.1
194
1152
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.8
9.9
62
225
XLD10
NOMESCO Finland
Gynaecological examination
8.1
9.8
21
26
8308
FHL
Hysterectomy and bilateral adnexal removal
2.1
9.8
109
532
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
26.1
9.8
13
5
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
10.6
9.8
18
17
N81.6
ICD-10 Finland
Rectocele
0.6
9.7
117
2015
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
5.6
9.6
27
49
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
9.5
78
329
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.8
9.4
30
63
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.4
9.4
43
126
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
100.3
9.4
10
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
100.3
9.4
10
*
HA1SA
NOMESCO Finland
Expansion mammography
17.6
9.4
14
8
394
Kela drug reimbursment
Palbociclib
+∞
9.4
9
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
9.4
9
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
9.4
9
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
9.4
9
*
8010/3-C54.1
ICD-O-3
Carcinoma, NOS, of endometrium
+∞
9.4
9
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
9.4
9
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
9.4
9
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
9.4
9
*
L01XE11
ATC
[U] pazopanib; oral
+∞
9.4
9
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
9.4
9
*
1501
Kela drug reimbursment
Palbociclib
+∞
9.4
9
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
9.4
9
*
R03BA01
ATC
beclometasone; inhalant
0.6
9.3
192
2918
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
10.7
9.3
17
16
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
9.2
90
414
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
9.2
104
509
UKC02
NOMESCO Finland
Cystoscopy
1.5
9.1
286
1931
B29
ICPC
Lymph/immune mech sympt/complt other
7.7
9.1
20
26
TPX15
NOMESCO Finland
Removal of vascular injection port
11.5
9.1
16
14
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
9.0
2239
20971
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
36.8
9.0
11
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
10.1
9.0
17
17
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.7
9.0
272
3835
SPAT1125
SPAT
Stoma care and guidance
3.0
9.0
50
170
P01AB01
ATC
metronidazole; oral, rectal
1.3
8.9
1025
8667
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
8.9
928
7747
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
8.0
8.8
19
24
T90
ICPC
Diabetes non-insulin dependent
1.4
8.8
577
4497
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
9.5
8.8
17
18
R03DC03
ATC
montelukast; oral
0.6
8.7
206
3047
K56.7
ICD-10 Finland
Ileus, unspecified
3.3
8.7
41
124
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
50.1
8.7
10
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
50.1
8.7
10
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
8.6
52
187
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.5
8.6
56
1153
N93.8
ICD-10 Finland
Other specified abnormal uterine and vaginal bleeding
2.9
8.5
50
176
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.0
8.5
101
506
J45
ICD-10 Finland
Asthma
0.6
8.5
113
1896
A10BA02
ATC
metformin; oral
1.3
8.5
688
5534
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
5.1
8.5
25
49
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
8.4
92
448
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
90.3
8.4
9
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
8.3
592
4666
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
8.3
8
*
192
Kela drug reimbursment
Fulvestrant
+∞
8.3
8
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.3
8
*
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
+∞
8.3
8
*
KKA10
NOMESCO Finland
Biopsy of retroperitoneal tissue
+∞
8.3
8
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
8.3
8
*
8980/3-C54.2
ICD-O-3
Carcinosarcoma, NOS, of myometrium
+∞
8.3
8
*
1CD01
NOMESCO Finland
NA
+∞
8.3
8
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
8.3
8
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
8.3
8
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
8.3
8
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
8.3
8
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
8.3
8
*
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
10.8
8.3
15
14
N02AX02
ATC
tramadol; systemic, rectal
1.3
8.2
1012
8609
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
14.5
8.2
13
9
ZX050
NOMESCO Finland
Stereotactic radiotherapy
14.5
8.2
13
9
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
8.2
73
325
UJF32
NOMESCO Finland
Coloscopy
1.3
8.2
663
5327
KBV00
NOMESCO Finland
Insertion of stent into ureter
6.5
8.2
20
31
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
33.4
8.1
10
*
SPAT1262
SPAT
Handing over of treatment supplies
1.4
8.0
434
3269
JFF10
NOMESCO Finland
Loop enterostomy
10.0
8.0
15
15
S77
ICPC
Malignant neoplasm of skin
13.1
7.9
13
10
WX234
NOMESCO Finland
Paracervical blockade
3.5
7.9
35
102
ZX100
NOMESCO Finland
Oral
3.3
7.7
36
109
X14
ICPC
Vaginal discharge
3.1
7.7
40
131
Z3231
NOMESCO Finland
Registered nurse
1.3
7.7
585
4652
N99.3
ICD-10 Finland
Prolapse of vaginal vault after hysterectomy
0.3
7.7
15
507
N84.1
ICD-10 Finland
Polyp of cervix uteri
2.0
7.6
95
489
TQB05
NOMESCO Finland
Puncture of skin of trunk
18.4
7.6
11
6
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
8.0
7.6
16
20
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
25.1
7.6
10
*
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.5
7.5
256
1759
Z93.3
ICD-10 Finland
Colostomy status
8.9
7.5
15
17
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
10.0
7.5
14
14
A08
ICPC
Swelling
1.8
7.5
125
711
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.7
7.5
49
186
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.7
7.4
30
81
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
80.3
7.4
8
*
PJW99
NOMESCO Finland
Other operation on lymphatic system
80.3
7.4
8
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
80.3
7.4
8
*
C03CA01
ATC
furosemide; systemic
1.3
7.4
840
7047
JN6AD
NOMESCO Finland
CT of torso and neck
8.4
7.3
15
18
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.9
7.3
103
556
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
7.3
7
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
7.3
7
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
7.3
7
*
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
7.3
7
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
7.3
7
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
7.3
7
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
7.3
7
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
7.3
7
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
7.3
7
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.3
7
*
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
+∞
7.3
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
L01CA04
ATC
vinorelbine; systemic
+∞
7.3
7
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
7.3
7
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
7.3
7
*
18221
ICD-8 Finland
NA
+∞
7.3
7
*
KCD10
NOMESCO Finland
Partial cystectomy
+∞
7.3
7
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
7.3
7
*
1CD02
NOMESCO Finland
NA
+∞
7.3
7
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
7.3
7
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
7.3
7
*
JFA70
NOMESCO Finland
Suture of small intestine
10.9
7.3
13
12
N71.1
ICD-10 Finland
Chronic inflammatory disease of uterus
6.8
7.3
17
25
U06
ICPC
Haematuria
2.7
7.3
45
166
G02BA03
ATC
plastic IUD with progestogen
0.5
7.2
49
994
6170A
ICD-9 Finland
Endometriosis of uterus
0.1
7.1
*
263
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
30.1
7.1
9
*
C90.0
ICD-10 Finland
Multiple myeloma
30.1
7.1
9
*
M05BA02
ATC
clodronic acid; systemic
20.1
7.1
10
5
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
20.1
7.1
10
5
JG1BG
NOMESCO Finland
MRI of rectum
20.1
7.1
10
5
JG1CG
NOMESCO Finland
Extensive MRI of rectum
20.1
7.1
10
5
KBV10
NOMESCO Finland
Removal of stent from ureter
6.6
7.1
17
26
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
12.0
7.1
12
10
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
0.6
7.1
119
1892
SPAT1088
SPAT
Blood transfusion
6.0
7.1
18
30
J45.1
ICD-10 Finland
Nonallergic asthma
0.5
7.0
71
1280
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.9
7.0
102
553
R03BB04
ATC
tiotropium bromide; inhalant
0.6
6.9
85
1454
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.5
6.9
61
1144
R60.0
ICD-10 Finland
Localized oedema
1.4
6.9
304
2208
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.0
6.9
36
120
6271A
ICD-9 Finland
Menopausal and postmenopausal disorders, Postmenopausal bleeding
2.2
6.8
66
307
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
6.8
117
673
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.7
6.8
16
24
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
6.8
186
1221
LAE20
NOMESCO Finland
Bilateral oophorectomy
4.2
6.8
24
58
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
9.3
6.8
13
14
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.7
764
6399
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
6.5
423
5312
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
6.5
640
5255
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.6
6.5
115
1803
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
6.5
27
76
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
6.5
319
4165
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
5.3
6.5
18
34
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
70.0
6.4
7
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
70.0
6.4
7
*
R31
ICD-10 Finland
Unspecified haematuria
1.6
6.4
144
897
LEE00
NOMESCO Finland
Suture of vagina
7.4
6.4
14
19
TQW20
NOMESCO Finland
Tatoe
14.3
6.4
10
7
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
11.0
6.3
11
10
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
11.0
6.3
11
10
R03AC02
ATC
salbutamol; inhalant
0.8
6.3
1038
11739
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
18.0
6.3
9
5
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
6.2
6
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
6.2
6
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
6.2
6
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
6.2
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.2
6
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
6.2
6
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
6.2
6
*
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
+∞
6.2
6
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
6.2
6
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
6.2
6
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
6.2
6
*
8310/3-C56.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of ovary
+∞
6.2
6
*
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
+∞
6.2
6
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
+∞
6.2
6
*
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
6.2
6
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
6.2
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.2
6
*
L01XE33
ATC
[U] palbociclib; oral
+∞
6.2
6
*
C78.5
ICD-10 Finland
Secondary malignant neoplasm of large intestine and rectum
+∞
6.2
6
*
8020/3-C54.1
ICD-O-3
Carcinoma, undifferentiated, NOS, of endometrium
+∞
6.2
6
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
6.2
6
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
6.2
6
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
6.2
6
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
6.2
6
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
6.2
6
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
6.2
6
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
6.2
565
4588
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
26.7
6.2
8
*
GDC00
NOMESCO Finland
Lobectomy of lung
26.7
6.2
8
*
M03BX02
ATC
tizanidine; oral
0.8
6.2
1199
13360
R01AD09
ATC
mometasone; nasal
0.8
6.2
780
9077
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
6.2
1075
9433
Y60.0
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation
5.0
6.2
18
36
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.7
6.2
40
151
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.4
6.2
47
194
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
6.1
235
3185
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
6.1
284
2081
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
6.1
70
1217
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
3.9
6.1
23
60
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
8.6
6.0
12
14
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
6.0
20
46
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
6.7
6.0
14
21

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1714
1584
19.74
307.65
4.8
1.5
u/ml
46.1
28.7
1.22
1686
1491
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
703
687
12.47
307.65
1.3
1.4
pmol/l
195.2
82.5
4.70
693
669
(4035726)
962
842
15.23
307.65
1.6
1.2
—
—
—
0
0
(4281824)
864
206
54.87
307.65
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2383
12712
3.59
288.68
4.7
3.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
233
172
14.41
252.60
1.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2006
10544
3.04
230.69
2.6
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1691
8429
2.90
208.61
2.3
2.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
137
68
20.90
180.52
1.1
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2213
13429
2.68
175.01
4.3
3.5
g/l
34.7
35.6
9.14
2099
12124
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1268
6424
2.50
138.36
2.3
2.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
632
2248
3.20
135.94
1.6
2.0
g/l
0.2
0.2
7.38
607
2028
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
555
1842
3.38
133.67
3.1
1.4
ug/l
5.4
12.9
0.52
438
1393
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
110
79
14.33
120.51
2.3
1.1
u/ml
26.8
17.3
1.85
101
70
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1161
6002
2.38
117.61
1.4
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2187
14797
2.22
113.25
6.5
3.5
umol/l
10.3
10.8
0.87
2078
13647
(3002173) Hemoglobin [Mass/volume] in Arterial blood
624
2522
2.78
104.77
4.5
6.2
g/l
118.9
119.0
0.04
611
2416
(3002256) Pathology report gross observation
590
2322
2.84
104.15
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
718
3125
2.62
104.04
4.5
5.6
mmol/l
1.2
1.6
2.33
570
2455
(3003694) ABO and Rh group [Type] in Blood
1174
6374
2.25
103.55
1.4
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
897
4375
2.40
101.50
3.8
2.1
mmol/l
0.8
0.8
7.18
837
3914
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
715
3140
2.59
101.49
4.5
5.6
kpa
5.3
5.1
5.34
689
2976
(3027801) Oxygen [Partial pressure] in Arterial blood
713
3137
2.59
100.75
4.5
5.6
kpa
13.6
11.7
14.51
688
2968
(3023368) Bacteria identified in Blood by Culture
1246
7343
2.07
85.73
4.3
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2222
16093
1.99
84.02
11.0
6.3
e9/l
4.0
4.2
2.37
1943
13646
(3043409) Potassium [Moles/volume] in Arterial blood
295
884
3.55
81.97
3.3
3.8
mmol/l
3.8
3.8
0.08
283
844
(3008152) Bicarbonate [Moles/volume] in Arterial blood
465
1845
2.75
79.60
5.6
6.1
mmol/l
25.0
25.0
0.06
448
1704
(3016502) Oxygen saturation in Arterial blood
607
2764
2.44
78.06
4.5
5.9
%
97.1
95.3
18.78
589
2644
(3019060) Gas panel - Arterial blood
470
1912
2.68
76.46
3.4
4.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
405
1591
2.74
70.31
4.8
6.8
%
95.0
93.4
10.28
405
1586
(3033658) Prothrombin time (PT) actual/Normal
1117
6921
1.89
62.35
3.3
3.3
%
94.7
91.8
3.42
1091
6717
(3020891) Body temperature
320
1193
2.85
61.09
3.7
4.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1594
11098
1.78
60.20
3.4
2.1
mmol/l
2.4
2.4
0.09
1391
9093
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
37
13
28.75
55.02
1.1
1.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
40
18
22.46
54.44
1.6
1.0
ug/l
2.5
1.6
0.93
22
12
(3013826) Glucose [Moles/volume] in Serum or Plasma
2283
17982
1.74
52.73
4.4
3.9
mmol/l
6.9
6.7
3.35
2182
16655
(3032080) INR in Blood by Coagulation assay
1689
12283
1.71
52.12
8.6
9.3
inr
1.2
1.2
2.01
512
3378
(40768793) Breast Pathology biopsy report
126
284
4.56
51.68
1.3
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
627
3408
2.02
50.16
5.4
5.1
mmol/l
104.2
103.7
1.64
613
3335
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2136
16733
1.68
48.20
5.9
5.2
mmol/l
1.2
1.2
29.34
1760
13883
(40758558) Short blood count panel - Blood
1054
6840
1.76
48.15
8.4
4.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2800
23648
1.83
47.94
8.0
5.4
u/l
85.1
76.6
9.40
2642
21634
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1945
15022
1.64
45.03
5.2
4.7
mmol/l
1.2
1.2
25.10
1764
13112
(3031040) Bacteria [#/volume] in Urine by Automated count
2595
21845
1.67
40.21
6.1
5.4
e6/l
1037.7
3417.9
3.10
62
282
(3009261) Glucose [Presence] in Urine by Test strip
2035
16226
1.58
38.63
4.8
4.5
estimate
0.0
0.0
1.08
380
2710
(3026008) Bacteria identified in Urine by Culture
1659
12673
1.57
37.53
4.1
3.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2014
16086
1.57
37.41
6.1
5.9
estimate
0.0
0.0
0.80
377
2670
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
534
3066
1.87
35.34
3.7
3.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
411
2171
2.01
34.82
4.9
6.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
37
5
74.88
32.87
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
195
787
2.56
31.55
2.6
3.0
u/ml
0.4
0.4
0.82
107
475
(3014111) Lactate [Moles/volume] in Serum or Plasma
417
2375
1.85
27.94
4.5
5.0
mmol/l
1.2
1.4
2.61
406
2293
(3042936) Bacteria identified in Isolate by Culture
583
3673
1.70
27.60
2.1
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
384
2168
1.86
26.39
6.0
5.5
mmol/l
9.6
10.4
1.07
361
2028
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
396
2276
1.83
25.68
1.6
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
217
1016
2.21
25.10
2.1
1.7
ug/l
4.5
2.0
0.95
186
855
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
674
4518
1.60
24.76
8.1
7.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
159
671
2.43
23.40
2.7
1.8
u/ml
113.7
74.3
0.40
128
535
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1150
8748
1.46
23.16
4.1
2.5
u/l
31.5
31.0
0.18
1097
8150
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
444
2731
1.71
22.67
3.7
2.8
u/l
250.3
244.5
0.40
415
2525
(3002582) Erythrocytes [#/volume] in Urine
1172
9004
1.45
22.19
3.3
3.2
e6/l
66.6
73.6
0.12
892
6670
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
256
1352
1.96
21.44
5.6
7.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
38
67
5.72
20.69
2.9
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1126
8675
1.43
20.66
5.6
4.9
estimate
0.0
0.0
0.50
370
2702
(3018418) pH of Serum or Plasma
1271
10041
1.41
20.13
3.4
3.2
ph
7.4
7.4
0.52
256
1687
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
27
34
7.99
20.01
2.5
1.3
ng/l
138.3
71.3
—
9
8
(3018095) Leukocytes [#/volume] in Urine
1358
10869
1.40
19.87
4.0
3.7
e6/l
224.3
136.3
1.22
969
7310
(3007853) Bacteria identified in Skin by Aerobe culture
499
3294
1.60
19.15
1.8
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
120
492
2.49
18.84
1.2
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
456
2957
1.62
18.82
4.1
3.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1056
8166
1.41
18.56
3.1
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1081
8429
1.40
18.00
3.1
3.1
e6/l
0.6
0.5
0.55
810
6230
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
104
407
2.60
18.00
2.3
1.9
u/ml
91.3
49.8
0.53
91
361
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
129
567
2.32
17.39
1.4
2.3
g/l
4.2
3.5
4.06
124
536
(3039000) Anion gap in Blood
140
642
2.23
17.08
3.8
5.9
mmol/l
11.0
11.0
0.11
130
572
(3018572) Chloride [Moles/volume] in Blood
140
642
2.23
17.08
3.8
5.9
mmol/l
105.6
104.1
3.92
130
572
(3000850) Epithelial cells [#/volume] in Urine
846
6376
1.43
16.92
2.7
2.6
e6/l
7.7
7.3
0.24
721
5480
(3020630) Protein [Mass/volume] in Serum or Plasma
397
2576
1.61
16.25
3.6
1.5
g/l
65.9
66.6
1.25
358
2234
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
870
6630
1.41
16.24
3.0
2.4
mmol/l
2.5
2.5
6.52
778
5684
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3217
30261
1.59
16.20
18.1
13.5
mg/l
31.5
21.2
37.34
2757
23614
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
37
6.80
16.13
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
532
3699
1.51
16.02
4.6
4.0
mmol/l
1.0
1.0
0.04
479
3325
(3044889) 12 lead EKG panel
2465
22164
1.36
15.35
4.3
4.0
—
—
—
0
0
(3026782) Osmolality of Urine
780
5887
1.41
15.26
2.8
2.8
mosm/kgh2o
499.8
504.1
0.23
658
4890
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
368
2388
1.60
15.02
3.5
2.4
ml/min/173m2
58.8
61.4
0.83
162
988
(3049717) Cytology report of Urine Cyto stain
148
732
2.07
14.92
2.4
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
226
1292
1.80
14.78
3.6
4.4
%
1.7
1.6
1.14
213
1212
(3035350) Ketones [Presence] in Urine by Test strip
1844
16011
1.31
13.99
5.0
4.4
estimate
0.0
0.0
0.00
383
2701
(3007930) Methemoglobin/Hemoglobin.total in Blood
219
1285
1.75
13.12
3.7
4.4
%
0.9
0.9
0.06
206
1206
(3017181) Myelocytes/100 leukocytes in Blood
359
2393
1.56
13.01
3.0
3.6
%
1.4
0.7
2.86
130
475
(3037467) Urinalysis macro (dipstick) panel - Urine
2441
22247
1.30
11.82
5.6
5.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
47
151
3.14
11.79
1.3
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1512
12988
1.28
11.63
11.1
8.6
e9/l
0.0
0.0
0.20
1237
10565
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1428
12186
1.28
11.55
5.5
4.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
367
2526
1.50
11.44
5.5
4.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
994
8102
1.31
11.35
4.6
4.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
161
921
1.78
10.57
4.0
5.4
mmol/l
1.2
1.3
0.73
147
815
(3009214) Lutropin [Units/volume] in Serum or Plasma
46
158
2.94
10.33
1.2
1.2
u/l
24.2
21.8
0.34
38
116
(3027945) Reticulocytes/100 erythrocytes in Blood
445
3254
1.42
10.09
2.8
2.1
%
1.9
1.8
0.49
382
2790
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
118
622
1.93
10.05
1.5
2.0
%
92.0
93.2
0.22
111
569
(3018677) aPTT in Platelet poor plasma by Coagulation assay
568
4331
1.37
10.05
1.9
1.9
s
29.1
29.5
0.73
550
4172
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
387
2764
1.45
9.98
3.2
2.9
mmol/l
1.2
1.2
0.43
333
2264
(40760892) CBC W Ordered Manual Differential panel - Blood
753
6000
1.32
9.92
4.4
4.2
—
—
—
0
0
(3036489) Thrombin time
157
915
1.75
9.69
1.5
1.8
s
21.1
21.2
0.10
140
795
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1173
9928
1.27
9.68
2.8
2.3
u/l
54.8
58.3
1.52
1073
8941
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
255
1687
1.55
9.55
1.4
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
218
1397
1.60
9.38
3.2
2.5
e6/l
0.2
0.3
1.28
211
1348
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
125
689
1.84
9.31
1.8
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
113
603
1.90
9.30
1.6
2.2
%
230.6
189.1
4.47
107
570
(3021440) Promyelocytes/100 leukocytes in Blood
329
2311
1.47
9.25
2.9
3.6
%
0.3
0.1
3.21
105
444
(3021447) Carbon dioxide [Partial pressure] in Venous blood
382
2771
1.42
9.04
2.9
3.3
kpa
5.8
5.9
1.43
370
2699
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
512
3928
1.35
8.64
2.4
2.5
%
18.6
20.8
3.09
416
3200
(3002179) Metamyelocytes/100 leukocytes in Blood
314
2226
1.45
8.42
2.8
3.4
%
0.7
0.6
0.53
78
353
(3019550) Sodium [Moles/volume] in Serum or Plasma
3330
32167
1.47
8.36
22.2
16.2
mmol/l
139.4
139.8
8.98
3277
31215
(3019150) Specific gravity of Urine by Refractometry
887
7369
1.27
8.30
5.7
5.1
kg/l
1.0
1.0
0.47
99
1170
(3024354) Oxygen [Partial pressure] in Venous blood
328
2351
1.43
8.29
2.6
2.8
kpa
4.4
4.4
0.05
317
2284
(3004809) Band form neutrophils/100 leukocytes in Blood
73
348
2.12
8.26
2.2
2.9
%
1.5
1.0
0.73
58
263
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
51
211
2.44
8.06
2.7
1.8
u/l
1276.6
1668.6
0.10
23
97
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
23
60
3.85
7.96
1.8
1.1
ug/l
0.5
2.4
—
10
43
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
657
5283
1.30
7.93
2.7
2.6
e6/l
1.7
1.5
0.46
364
2965
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
591
4687
1.31
7.90
2.9
2.8
e6/l
4.9
4.8
0.09
303
2388
(3004789) Transferrin [Mass/volume] in Serum or Plasma
540
4229
1.33
7.89
2.3
2.4
g/l
2.3
2.4
3.75
486
3825
(3002032) Base excess in Venous blood by calculation
374
2770
1.39
7.84
2.9
3.3
mmol/l
2.2
2.2
0.02
302
2300
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
823
6821
1.27
7.79
1.5
1.7
mg/l
1.9
1.2
3.70
655
5207
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
40
4.52
7.64
5.3
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3330
32234
1.44
7.57
22.2
16.3
mmol/l
4.0
4.0
0.03
3273
31222
(3019198) Lymphocytes [#/volume] in Blood
1672
14995
1.21
7.50
5.3
5.4
e9/l
1.7
1.9
2.39
1419
12938
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2891
30203
0.78
7.49
4.5
4.8
mmol/l
1.5
1.6
13.86
2543
27201
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
612
4923
1.29
7.32
1.7
1.8
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
53
235
2.27
7.21
1.3
1.5
g/l
33.0
27.5
2.34
45
197
(3006315) Basophils [#/volume] in Blood
1635
14686
1.21
7.06
5.1
5.4
e9/l
0.0
0.0
4.22
1373
12454
(3022948) Iron [Moles/volume] in Serum or Plasma
581
4668
1.29
7.00
2.3
2.4
umol/l
10.9
12.2
4.75
526
4208
(3001604) Monocytes [#/volume] in Blood
1624
14595
1.21
6.93
5.1
5.4
e9/l
0.6
0.6
1.26
1362
12378
(40761511) CBC panel - Blood by Automated count
3232
31191
1.35
6.91
18.6
13.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2925
30459
0.79
6.85
4.5
4.8
mmol/l
4.8
4.8
1.25
2585
27629
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1217
10662
1.21
6.72
2.9
3.0
ng/l
1687.7
1390.9
0.90
1053
9140
(3025159) Blasts/100 leukocytes in Blood
302
2218
1.39
6.66
3.0
3.7
%
0.0
0.3
0.56
86
393
(3023199) Leukocytes [#/volume] in Pleural fluid
49
218
2.26
6.64
1.3
1.5
e6/l
955.2
2001.5
1.04
33
164
(3028308) Erythrocytes [#/volume] in Pleural fluid
45
193
2.35
6.63
1.3
1.5
e6/l
45395.8
51913.1
0.07
24
112
(3013115) Eosinophils [#/volume] in Blood
1679
15190
1.20
6.52
5.3
5.5
e9/l
0.2
0.2
6.36
1427
13092
(3025130) Human papilloma virus identified in Specimen
71
369
1.94
6.44
1.4
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1938
17780
1.19
6.39
3.5
2.9
u/l
52.0
42.3
3.90
1771
16027
(3012544) pH of Venous blood
373
2855
1.34
6.35
2.8
3.3
ph
7.4
7.4
—
5
9
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
462
5773
0.77
6.26
1.2
1.3
u/ml
10.9
15.4
0.86
184
2063
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
44
192
2.31
6.26
1.5
1.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(40758358) Immune stain study
6
0
+∞
6.25
1.0
0.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1539
13851
1.19
6.23
5.3
5.8
%
25.4
28.1
15.21
1415
12608
(3023520) Reticulocytes [#/volume] in Blood
325
2453
1.36
6.07
3.0
2.2
e9/l
73.1
71.2
0.35
238
1829
(3019069) Monocytes/100 leukocytes in Blood
1504
13576
1.19
5.74
5.4
5.9
%
8.5
8.5
0.09
1396
12441
(42870588) Differential panel, method unspecified - Blood
1125
9901
1.20
5.72
4.8
5.3
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
9
7
12.88
5.58
1.1
4.6
umol/l
1953.8
204.0
—
9
7
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
147
978
1.52
5.48
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
53
265
2.01
5.42
1.6
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
143
950
1.53
5.38
1.4
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
394
3115
1.30
5.34
2.6
2.0
umol/l
9.5
6.5
1.31
334
2606
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2981
28656
1.23
5.27
18.3
12.4
ml/min/173m2
73.5
73.8
0.26
2599
22811
(3006504) Eosinophils/100 leukocytes in Blood
1489
13512
1.17
5.15
5.1
5.6
%
2.6
2.9
6.64
1376
12315
(3018010) Neutrophils/100 leukocytes in Blood
1509
13715
1.17
5.11
5.2
5.6
%
59.3
57.3
7.01
1395
12550
(3008757) Leukocyte morphology finding [Identifier] in Blood
48
239
2.02
4.99
2.3
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
498
6009
0.80
4.95
1.2
1.3
iu/ml
49.9
37.7
0.64
164
1940
(3006184) Hemoglobin [Mass/volume] in Capillary blood
109
695
1.59
4.94
2.6
2.1
g/l
125.9
127.4
0.28
80
508
(3021901) Oxygen saturation in Capillary blood
80
472
1.71
4.91
3.2
2.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
35
156
2.26
4.81
1.7
1.9
umol/l
18.8
15.1
—
5
15
(3037756) Immunofixation for Serum or Plasma
99
629
1.59
4.58
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3031
31218
0.82
4.58
5.1
5.5
mmol/l
2.8
2.8
0.03
2671
28230
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1418
12905
1.16
4.57
3.9
3.9
ng/l
33.6
79.3
1.27
1086
9106
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
104
2.51
4.54
1.7
1.6
%
15.5
15.6
0.00
11
42
(3022096) Basophils/100 leukocytes in Blood
1438
13107
1.16
4.53
5.2
5.6
%
0.6
0.7
3.44
1333
11955
(40767503) Oxygen content in Capillary blood by calculation
95
600
1.60
4.51
2.9
2.4
%
15.9
16.1
0.25
55
306
(3010421) pH of Blood
113
743
1.54
4.51
3.0
3.1
ph
7.4
7.4
0.15
89
603
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
118
784
1.52
4.49
2.4
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
93
585
1.61
4.49
2.8
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
916
8065
1.18
4.45
4.9
4.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
924
8145
1.18
4.42
2.3
2.4
mg/l
3.3
3.0
2.23
782
6890
(1175426) CD3 cells/100 lymphocytes in Blood
26
106
2.46
4.37
1.7
1.6
%
71.0
72.4
0.19
26
100
(3037522) Nuclear Ab [Titer] in Serum
347
4298
0.79
4.31
1.3
1.3
titre
519.4
589.6
0.31
66
1051
(3044242) Glucose [Moles/volume] in Arterial blood
30
132
2.28
4.28
3.3
2.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
56
314
1.80
4.15
3.5
3.8
iu/ml
189.4
579.7
—
8
35
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
790
8964
0.85
4.03
1.6
1.6
mmol/l
1.5
1.3
6.15
628
7390
(3040151) Glucose [Moles/volume] in Capillary blood
60
348
1.74
3.98
4.6
6.6
mmol/l
7.6
7.2
0.38
49
287
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
211
1600
1.34
3.90
4.1
3.2
mmol/l
1.7
2.4
1.16
155
1233
(3002385) Erythrocyte distribution width [Ratio]
2541
24282
1.16
3.86
23.0
16.3
%
14.2
13.7
24.39
2495
23635
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2818
29129
0.85
3.85
4.0
4.2
mmol/l
1.4
1.3
10.56
2451
25903
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
418
3466
1.23
3.81
1.6
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
153
1107
1.40
3.80
1.9
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
84
1277
0.65
3.78
1.3
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
392
3235
1.24
3.74
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
43
230
1.88
3.73
2.5
2.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
96
2.40
3.72
1.9
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
217
1666
1.32
3.70
4.1
3.3
ph
7.4
7.4
0.20
42
233
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
367
3015
1.24
3.65
2.4
2.5
ug/l
4.5
5.8
1.57
307
2497
(3033799) Differential panel - Peritoneal fluid
14
45
3.12
3.64
1.1
2.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
35
176
2.00
3.63
1.3
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
35
3.44
3.61
1.0
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
99
668
1.50
3.58
3.9
2.8
mmol/l
25.4
25.6
0.14
90
591
(3012441) Differential panel - Pleural fluid
35
177
1.99
3.58
1.3
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
197
1501
1.33
3.56
2.2
2.4
%
1.2
1.1
0.47
197
1492
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
218
1686
1.31
3.54
4.1
3.3
kpa
5.3
5.2
0.08
201
1544
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
194
1476
1.33
3.54
2.2
2.4
%
0.7
0.7
1.53
184
1412
(3001019) Free T4 and TSH panel - Serum or Plasma
67
1051
0.63
3.50
1.6
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
615
7035
0.85
3.40
1.2
1.3
u/ml
1.2
1.7
0.86
164
1787
(3017143) Hepatitis C virus Ab [Presence] in Serum
251
1997
1.28
3.31
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
159
1188
1.35
3.29
1.9
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
134
974
1.39
3.29
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
28
135
2.08
3.27
1.8
1.8
e9/l
1.1
1.1
0.11
22
78
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
54
323
1.68
3.27
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
133
969
1.39
3.23
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
193
2475
0.77
3.20
1.5
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
14
49
2.86
3.19
2.4
2.0
%
41.8
47.8
—
8
19
(3035880) pH of Pleural fluid
21
91
2.32
3.17
1.3
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
412
3480
1.21
3.15
1.6
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
97
671
1.46
3.14
1.8
2.4
ug/min
81.0
61.0
0.30
49
379
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
131
957
1.38
3.14
1.2
1.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
15
56
2.69
3.05
1.1
2.5
e6/l
1120.7
781.3
—
7
35
(3012501) Base excess in Blood by calculation
90
620
1.46
2.99
2.9
3.3
mmol/l
2.8
2.8
0.06
63
432
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1457
15588
0.89
2.94
2.3
2.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3290
32284
1.22
2.86
13.0
9.6
u/l
23.6
22.7
2.60
3173
30674
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
69
1024
0.67
2.84
1.8
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
333
3957
0.83
2.83
1.4
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
47
2.77
2.81
2.2
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
15
59
2.55
2.78
1.9
1.6
—
—
—
0
0
(3013512) EKG study
1089
9997
1.13
2.77
4.4
4.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
6
8.34
2.75
1.6
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
104
2.12
2.74
1.1
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
50
311
1.62
2.67
1.4
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
264
2176
1.23
2.61
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1357
12655
1.12
2.60
2.7
2.8
ug/l
153.3
103.2
9.74
1223
11413
(3022217) INR in Platelet poor plasma by Coagulation assay
511
4474
1.17
2.60
26.9
28.4
inr
1.4
1.4
0.11
55
598
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
169
1323
1.29
2.59
6.7
6.7
mmol/l
24.5
24.8
0.57
158
1210
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
37
214
1.74
2.59
1.3
1.3
u/l
41.4
43.4
0.12
27
151
(3051387) C reactive protein [Mass/volume] in Capillary blood
98
708
1.39
2.57
3.7
3.8
mg/l
29.3
23.6
0.74
70
451
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
39
231
1.70
2.52
1.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
45
278
1.63
2.49
1.2
1.3
u/ml
119.4
122.5
0.10
14
61
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
496
1.46
2.46
1.3
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
166
1310
1.28
2.41
3.0
3.5
mmol/l
24.4
24.6
0.25
140
1169
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
33
190
1.74
2.37
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
33
190
1.74
2.37
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
33
190
1.74
2.37
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
230
1892
1.23
2.34
1.6
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
36
214
1.69
2.32
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
314
2667
1.19
2.31
2.1
2.1
u/l
36.1
37.7
0.13
258
2241
(40768441) Liver Pathology biopsy report
25
133
1.89
2.31
1.0
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
326
2780
1.19
2.30
2.5
1.8
nmol/l
398.7
373.9
1.28
297
2470
(3044007) Cell count panel - Peritoneal fluid
12
47
2.56
2.27
1.2
2.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
126
968
1.31
2.26
4.3
5.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
62
892
0.69
2.24
1.5
1.3
u/ml
2.2
5.0
—
5
116
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
88
641
1.38
2.24
1.7
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
25
135
1.86
2.22
4.5
1.1
u/ml
97.0
153.2
—
7
38
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
70
491
1.43
2.21
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
42
264
1.60
2.20
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
80
576
1.40
2.19
1.9
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
38
234
1.63
2.16
2.3
2.5
%
64.3
60.4
0.41
26
155
(3012516) Albumin [Mass/volume] in Urine
1067
9904
1.11
2.16
3.1
3.0
mg/l
420.2
433.8
0.03
640
5522
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
249
2088
1.21
2.12
3.8
2.8
pmol/l
4.4
4.4
0.04
220
1787
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
64
904
0.70
2.11
1.5
1.3
u/ml
24.1
5.6
—
10
178
(4010399)
209
2519
0.82
2.10
1.4
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
49
2.45
2.10
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
54
785
0.68
2.09
1.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
57
389
1.47
2.08
1.1
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
273
3206
0.84
2.08
2.6
3.0
ng/l
192.8
200.2
0.11
246
2921
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
10
5.00
2.07
1.0
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
25
139
1.80
2.04
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
25
139
1.80
2.04
1.3
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
104
1350
0.76
2.00
1.3
1.3
u/ml
1.1
0.9
0.10
18
130
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
61
426
1.44
2.00
1.3
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
9
32
2.82
2.00
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
216
2578
0.83
1.98
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1083
10099
1.10
1.98
3.1
3.0
mmol/l
6.3
6.0
1.36
893
8338
(3023183) Ammonium ion [Moles/volume] in Plasma
60
419
1.44
1.97
2.4
2.5
umol/l
36.7
31.7
0.55
50
357
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
230
0.43
1.97
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
383
4354
0.87
1.96
4.5
4.9
%
32.9
34.2
1.40
220
2771
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
95
719
1.33
1.94
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1118
10457
1.10
1.91
4.0
3.8
mg/mmol
8.1
7.8
0.08
664
5884
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
22
3.19
1.88
1.1
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
175
2116
0.82
1.85
1.5
1.5
%
1.4
1.4
0.10
149
1812
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
408
1.43
1.85
1.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
51
350
1.46
1.85
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
52
359
1.45
1.83
1.5
1.3
—
—
—
0
0
(1002224) Polysomnography panel
60
831
0.72
1.81
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
72
529
1.37
1.80
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
71
521
1.37
1.79
3.0
3.4
%
60.3
57.8
0.85
71
521
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
130
1039
1.26
1.78
2.0
1.5
mg/l
39.3
34.1
0.29
101
832
(3007164) IgA [Mass/volume] in Serum or Plasma
509
5637
0.89
1.76
1.3
1.3
g/l
2.4
2.4
0.35
270
2974
(3034860) Kappa light chains.free [Mass/volume] in Serum
130
1041
1.26
1.76
2.0
1.5
mg/l
36.6
39.0
0.36
102
839
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
57
404
1.42
1.76
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
815
7535
1.11
1.75
2.5
2.2
umol/l
5185.2
6067.3
0.19
660
6230
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
13
3.85
1.71
1.2
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
44
299
1.48
1.70
1.1
1.2
u/ml
295.8
296.6
0.01
20
179
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2919
29748
0.90
1.69
5.6
5.6
mu/l
2.1
2.0
0.14
2611
26960
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
56
400
1.41
1.67
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
56
400
1.41
1.67
1.3
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
17
90
1.89
1.65
2.1
1.9
e9/l
0.1
0.2
0.49
17
85
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
63
461
1.37
1.64
1.2
1.2
nmol/l
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
57
411
1.39
1.62
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
56
403
1.40
1.61
1.2
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
23
136
1.70
1.58
3.7
2.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
64
856
0.74
1.58
1.9
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
72
542
1.34
1.58
1.4
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
24
144
1.67
1.57
2.5
2.0
mmol/l
10.5
9.2
0.77
19
107
(40760888) Immunoglobulin light chains.free panel - Serum
96
753
1.28
1.57
2.1
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
248
0.52
1.57
1.8
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
124
1004
1.24
1.56
3.3
2.3
g/l
0.3
0.3
0.01
50
246
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
159
1322
1.21
1.55
1.8
1.6
g/l
1.7
1.6
0.63
120
1133
(3003327) Ova and parasites identified in Stool by Light microscopy
77
999
0.77
1.54
1.5
1.7
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
15
3.34
1.52
1.2
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
182
0.49
1.50
1.3
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
29
441
0.65
1.49
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
68
513
1.33
1.48
1.4
1.3
—
—
—
0
0
(4094501)
62
823
0.75
1.47
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
94
1.81
1.47
1.2
1.1
—
—
—
0
0
(44806420)
19
109
1.75
1.46
2.8
2.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
162
1359
1.20
1.46
1.5
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
45
318
1.42
1.46
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
605
6566
0.91
1.46
3.7
4.0
ng/l
133.3
247.4
1.40
478
5309
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
123
1004
1.23
1.45
1.9
2.2
ug/l
882.0
820.5
0.05
116
935
(3021960) Folate [Moles/volume] in Serum or Plasma
909
8523
1.09
1.44
1.5
1.5
nmol/l
22.2
21.8
0.29
778
7054
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
57
421
1.36
1.43
1.2
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
145
1206
1.21
1.43
1.2
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
22
2.73
1.43
1.2
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
131
1582
0.82
1.43
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
46
328
1.41
1.42
1.5
1.4
e6/l
15942.9
175097.1
2.95
31
216
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2894
29448
0.91
1.42
6.7
6.3
mmol/mol
41.4
40.2
9.75
2615
26778
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
123
1008
1.23
1.41
2.0
1.5
ratio
1.4
1.4
—
7
85
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
174
2044
0.84
1.41
2.3
2.4
au/ml
20.8
32.4
—
9
79
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
83
651
1.28
1.39
2.2
2.4
—
—
—
0
0
(44790048)
36
247
1.46
1.37
1.5
1.3
—
—
—
0
0
(44790049)
36
247
1.46
1.37
1.5
1.3
—
—
—
0
0
(44790047)
36
247
1.46
1.37
1.5
1.3
—
—
—
0
0
(44806118)
36
247
1.46
1.37
1.5
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
41
2.20
1.37
1.8
2.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3358
33236
1.15
1.36
29.6
20.1
e9/l
260.1
258.1
0.86
3279
32147
(3013139) Helicobacter pylori Ag [Presence] in Stool
209
2411
0.86
1.36
1.1
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
17
2.94
1.36
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
62
811
0.76
1.35
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
32
215
1.49
1.35
1.3
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
66
855
0.77
1.34
1.5
1.7
mg/l
4.5
3.5
0.36
54
622
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
53
707
0.75
1.33
1.5
1.2
u/ml
51.5
46.2
—
8
93
(3022313) Gas panel - Capillary blood
140
1171
1.20
1.33
4.3
3.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3359
33253
1.15
1.33
29.6
20.1
e9/l
6.7
6.6
2.28
3274
32015
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
61
1.97
1.32
1.2
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
3358
33244
1.15
1.32
29.5
20.0
pg
30.1
30.2
3.62
3316
32580
(3024731) MCV [Entitic volume]
3358
33244
1.15
1.32
29.5
20.1
fl
91.3
91.3
0.02
3317
32581
(3034274) Bile acid [Moles/volume] in Serum --fasting
26
168
1.55
1.31
1.2
1.6
umol/l
9.6
9.3
0.03
20
113
(3026361) Erythrocytes [#/volume] in Blood
3358
33248
1.15
1.29
29.6
20.1
e12/l
4.3
4.4
37.24
3271
31999
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
137
1.61
1.29
1.7
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
42
301
1.40
1.29
1.3
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
69
1.89
1.28
1.1
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
3358
33253
1.15
1.26
29.8
20.2
g/l
126.9
131.5
69.28
3320
32595
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
158
1850
0.85
1.26
1.2
1.3
au/ml
39.9
50.1
—
7
81
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
154
1.56
1.25
1.4
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
49
654
0.75
1.25
1.6
1.5
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
6
25
2.40
1.24
1.5
2.9
ml/dl
14.9
14.5
—
6
20
(3000012) Reticulocyte production index
27
179
1.51
1.23
1.8
1.4
—
—
—
0
0
(3019977) pH of Arterial blood
23
147
1.57
1.22
4.3
2.5
ph
7.4
7.4
—
9
50
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
31
212
1.47
1.22
1.3
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
68
864
0.78
1.21
1.5
1.6
iu/ml
0.0
0.1
1.66
15
196
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
275
0.62
1.19
1.2
1.1
u/ml
0.6
0.6
—
5
115
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3030
30713
0.91
1.17
5.2
5.1
mmol/l
6.2
6.0
16.59
2668
27525
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
24
157
1.53
1.17
3.9
1.1
nmol/l
88.0
83.2
0.10
24
152
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
836
7882
1.08
1.15
1.7
1.7
pmol/l
27576228.7
28884731.9
0.02
660
6256
(3025941) Bacteria identified in Stool by Culture
196
1711
1.15
1.15
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
145
1236
1.18
1.15
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
123
1456
0.84
1.14
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
28
192
1.46
1.11
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
23
341
0.67
1.10
1.3
1.1
u/ml
0.8
1.3
—
5
133
(3000093) Morphology [Interpretation] in Blood Narrative
32
226
1.42
1.09
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.6
2.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
124
1049
1.19
1.09
4.2
3.5
mmol/l
24.5
25.4
1.94
111
941
(3002331) Protein [Mass/volume] in Peritoneal fluid
8
41
1.95
1.08
1.1
1.6
g/l
33.1
22.5
—
8
32
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
279
0.64
1.07
4.1
3.6
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
25
169
1.48
1.07
1.2
1.1
u/l
24.4
20.8
0.15
17
114
(3032057) Clostridioides difficile [Presence] in Stool
14
82
1.71
1.05
2.6
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
25
170
1.47
1.04
1.2
1.1
u/l
84.2
72.3
0.49
17
120
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
42
555
0.75
1.04
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
125
0.48
1.04
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2552
25996
0.94
1.02
4.8
4.6
pmol/l
15.1
15.1
1.03
2285
23380
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
151
0.53
1.02
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
139
1610
0.86
1.01
1.7
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
45
343
1.32
0.99
1.2
1.1
—
—
—
0
0
(4034850)
131
1128
1.17
0.96
13.3
10.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
73
595
1.23
0.96
2.6
2.7
mg/l
1.6
1.7
0.10
63
526
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
20
294
0.68
0.95
1.1
1.1
—
0.9
—
0
7
(3035947) Staphylolysin Ab [Units/volume] in Serum
19
125
1.52
0.93
1.1
1.1
—
2.3
—
0
7
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
58
462
1.26
0.93
1.3
1.2
miu/ml
304.3
232.1
0.45
19
204
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
27
2.22
0.93
10.8
11.9
mmol/l
3.9
4.6
—
6
27
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
29
396
0.73
0.92
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
262
2372
1.11
0.91
1.4
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
43
331
1.30
0.90
1.1
1.1
%
135.0
121.7
1.20
34
294
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
86
1.63
0.90
2.2
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
86
1.63
0.90
2.2
2.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
207
0.63
0.90
1.1
1.0
u/ml
3.3
3.2
—
5
78
(3008037) Lactate [Moles/volume] in Venous blood
91
765
1.19
0.89
3.0
3.2
mmol/l
1.7
1.6
0.43
91
748
(3047007) Chlamydophila sp Ab [Presence] in Serum
27
371
0.73
0.89
1.2
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
104
0.48
0.89
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
48
377
1.28
0.88
1.3
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
130
0.54
0.87
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
203
1.38
0.87
1.3
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
30
2.00
0.87
2.7
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
44
1.82
0.85
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
107
917
1.17
0.85
1.5
1.6
—
—
—
0
0
(4146454)
48
379
1.27
0.85
2.6
2.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
17
112
1.52
0.84
1.9
2.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
24
332
0.72
0.84
1.3
1.5
—
20.9
—
0
15
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
21
297
0.71
0.83
1.1
1.2
—
73.8
—
0
19
(3038026) Centromere Ab [Units/volume] in Serum
22
308
0.71
0.83
1.1
1.2
—
69.9
—
0
13
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
30
223
1.35
0.81
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
138
1.45
0.81
1.1
1.1
ratio
1.1
1.1
—
6
46
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
93
793
1.18
0.80
1.5
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
169
1506
1.13
0.80
1.5
1.5
g/l
1.1
1.3
1.55
152
1345
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
106
1225
0.86
0.80
1.5
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
23
164
1.40
0.79
1.6
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
252
2298
1.10
0.79
1.7
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
30
225
1.34
0.78
1.3
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
82
1.59
0.78
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
114
993
1.15
0.76
3.5
3.4
nmol/l
0.8
0.8
1.46
90
784
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
59
714
0.82
0.76
1.4
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
40
314
1.28
0.76
3.0
2.4
u/field
4.1
2.6
0.38
13
102
(3043410) Blood group antigens tested for on Red Blood Cells
10
59
1.70
0.75
2.3
1.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
20
279
0.72
0.75
1.4
1.3
—
566.9
—
0
29
(40768443) Skin Pathology biopsy report
152
1353
1.13
0.75
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44
351
1.26
0.74
1.2
1.2
u/ml
5.4
3.6
0.21
15
102
(3022493) Free Hemoglobin [Mass/volume] in Plasma
17
116
1.47
0.74
1.0
5.1
mg/l
89.0
64.0
0.34
12
73
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
380
0.76
0.74
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
133
0.60
0.73
1.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(4212803)
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
39
1.80
0.72
1.0
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
44
353
1.25
0.71
1.2
1.1
u/l
59.4
58.4
0.07
30
239
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
53
435
1.22
0.70
1.1
1.3
pmol/l
341.2
286.5
0.43
46
324
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
15
101
1.49
0.70
1.1
1.0
%
93.4
93.2
—
9
74
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
118
1.44
0.69
1.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
118
1.44
0.69
1.4
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
158
1756
0.90
0.69
1.3
1.3
u/ml
139.9
171.7
0.57
148
1612
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
191
2101
0.90
0.68
2.4
2.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
27
1.85
0.68
2.4
2.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
261
0.73
0.67
1.3
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
92
0.54
0.67
3.2
1.6
ug/l
10.9
9.1
—
5
92
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
17
119
1.43
0.66
1.4
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
55
457
1.21
0.66
1.2
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
28
1.79
0.66
2.4
2.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
75
642
1.17
0.65
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
75
642
1.17
0.65
1.2
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
23
171
1.35
0.65
2.0
2.2
u/field
2.1
3.0
0.31
17
106
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
190
0.68
0.65
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
13
190
0.68
0.65
1.1
1.1
u/ml
2.6
2.9
—
5
75
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1466
15033
0.96
0.63
2.3
2.3
nmol/l
79.7
81.4
1.66
1289
13062
(3032773) Endomysium IgG Ab [Titer] in Serum
18
246
0.73
0.62
1.3
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
223
0.72
0.62
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
686
0.84
0.62
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
121
1.41
0.62
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
211
0.71
0.62
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
14
199
0.70
0.61
1.6
1.4
ml
1081.6
1886.7
—
5
44
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
50
598
0.83
0.61
1.4
1.4
e6/l
6.6
20.5
1.31
41
466
(3011985) Renin [Units/volume] in Plasma
55
462
1.19
0.61
1.2
1.4
mu/l
43.9
46.7
0.08
50
410
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
141
0.64
0.60
1.1
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
221
0.72
0.60
1.0
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
29
227
1.28
0.59
1.2
1.3
nmol/l
1.9
1.4
1.15
29
202
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
11
72
1.53
0.59
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
355
0.79
0.59
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
220
0.73
0.58
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
220
0.73
0.58
1.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
23
0.00
0.58
0.0
1.8
—
1.8
—
0
18
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
38
464
0.82
0.58
1.4
1.5
%
63.1
58.0
0.46
26
277
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
150
0.67
0.58
1.0
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
82
716
1.15
0.58
1.2
1.3
mmol/l
58.9
61.5
0.26
65
578
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
106
1.42
0.57
1.2
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
106
1.42
0.57
1.2
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
106
1.42
0.57
1.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1035
10673
0.96
0.57
2.3
2.1
u/l
212.6
190.4
0.21
964
9864
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
219
0.73
0.57
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
219
0.73
0.57
1.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
108
962
1.13
0.57
3.8
3.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
218
0.73
0.56
1.0
1.2
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
5
86
0.58
0.56
2.2
2.1
—
3.6
—
0
37
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
25
319
0.78
0.56
1.1
1.1
u/ml
3.6
2.7
—
6
108
(3042631) Mycobacterium sp identified in Specimen
41
338
1.22
0.56
1.8
3.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
107
1.40
0.55
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
94
1059
0.88
0.55
1.5
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
38
1.58
0.54
1.0
1.2
nmol/l
43.0
70.1
—
6
38
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
95
844
1.13
0.53
1.5
1.5
g/l
0.0
0.0
0.00
81
764
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
99
882
1.13
0.53
1.5
1.7
iu/l
5.5
4.7
0.26
36
284
(3014891) Appearance of Pleural fluid
6
39
1.54
0.53
1.2
1.5
—
—
—
0
0
(44813793)
15
204
0.73
0.52
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
13
181
0.72
0.52
1.4
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
19
143
1.33
0.52
1.1
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
135
0.67
0.51
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
146
1596
0.91
0.51
1.9
2.0
—
—
—
0
0
(4268621)
30
242
1.24
0.51
2.2
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
42
352
1.20
0.50
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
21
162
1.30
0.50
1.2
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
156
0.70
0.49
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
67
1.49
0.49
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
10
67
1.49
0.49
1.0
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
32
261
1.23
0.49
1.1
1.5
g/l
7.1
6.7
0.21
26
181
(3003338) MCHC [Mass/volume]
2484
24543
1.04
0.49
26.5
18.3
g/l
328.7
329.9
10.41
2457
24350
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
84
1.43
0.49
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
18
136
1.33
0.49
1.2
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
96
860
1.12
0.48
1.5
1.4
g/l
0.0
0.0
0.00
81
766
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
58
668
0.87
0.48
1.9
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
212
0.75
0.48
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
93
1.40
0.48
1.4
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
179
1932
0.92
0.48
4.0
4.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
712
7370
0.96
0.48
1.8
1.8
nmol/l
1295.3
1205.3
1.46
526
5383
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
7
47
1.49
0.47
1.0
1.0
%
147.6
118.4
—
7
47
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
318
1.20
0.47
1.3
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
146
1.30
0.47
1.3
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
12
85
1.41
0.46
1.1
1.5
umol/l
3.7
2.4
0.66
12
78
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
197
2113
0.93
0.45
1.2
1.2
iu/ml
115.4
144.4
0.69
92
804
(3011436) Histone Ab [Units/volume] in Serum
5
83
0.60
0.45
1.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
11
152
0.72
0.44
1.9
1.9
ug/l
123.8
51.0
0.68
11
147
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
53
608
0.87
0.43
1.4
1.3
—
85.0
—
0
12
(3008536) Aspergillus sp Ab [Presence] in Serum
5
31
1.61
0.43
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
40
340
1.18
0.43
3.0
3.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
50
574
0.87
0.42
1.6
1.4
—
—
—
0
0
(4306422)
40
341
1.17
0.42
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
140
1.29
0.41
1.3
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
58
1.38
0.41
1.3
1.1
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
2.7
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
16
0.00
0.41
0.0
2.9
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
12
161
0.74
0.41
1.2
1.8
nmol/l
16.2
16.4
0.07
12
142
(3048689) Calprotectin [Mass/mass] in Stool
356
3729
0.95
0.41
1.8
1.9
ug/g
127.0
137.7
0.29
264
2832
(3016038) Potassium [Moles/volume] in Urine
31
259
1.20
0.40
1.0
1.2
mmol/l
36.1
33.7
0.25
26
205
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
123
1.30
0.40
2.9
4.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
24
195
1.23
0.40
1.2
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2601
26250
0.97
0.40
19.6
15.3
%
37.1
38.3
6.43
1578
16612
(3038515) Glucose [Moles/volume] in Venous blood
82
739
1.11
0.40
3.2
3.3
mmol/l
8.2
7.7
0.76
82
722
(3005719) IgG [Mass/volume] in Serum or Plasma
204
1916
1.07
0.39
2.4
2.4
g/l
10.2
10.5
0.45
183
1738
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
0.0
—
0
9
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
133
1.28
0.38
3.2
3.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
31
261
1.19
0.38
1.1
1.5
g/l
0.5
0.4
0.47
25
182
(3028192) IgG subclass 2 [Mass/volume] in Serum
31
261
1.19
0.38
1.1
1.5
g/l
2.8
2.7
0.10
25
178
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
214
0.79
0.38
1.4
1.5
u/l
7.5
9.2
—
6
92
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
68
1.32
0.37
1.3
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
70
629
1.12
0.37
1.1
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
20
161
1.24
0.37
1.5
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
10
72
1.39
0.36
8.6
5.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
30
353
0.85
0.36
1.1
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
201
0.80
0.35
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
66
593
1.12
0.35
2.2
2.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
26
217
1.20
0.35
1.5
1.9
%
9.0
10.8
1.47
26
217
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
21
255
0.82
0.35
1.0
1.1
—
68.9
—
0
6
(3013707) Erythrocyte sedimentation rate by Westergren method
2380
24028
0.97
0.35
4.1
4.5
mm/h
18.3
13.8
26.17
2137
22010
(3038177) Helicobacter pylori Ab [Presence] in Serum
40
458
0.87
0.34
1.3
1.3
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
6
44
1.36
0.34
1.0
1.0
—
84.8
—
0
8
(4198724)
6
44
1.36
0.34
1.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
45
1.33
0.33
3.3
3.1
u/field
0.3
0.8
—
6
45
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
349
1.15
0.33
1.2
1.2
u/ml
2.4
4.4
1.16
24
138
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
81
886
0.91
0.33
1.5